Nanalysis Scientific (TSXV: NSCI) is in search of funding. The firm last night announced that it is conducting a best efforts marketed public offering, the proceeds of which are to go towards sales and marketing.
Under the terms of the offering, the company is looking to raise up to $8.0 million via the sale of shares. Shares are priced at $1.10 per each, with no warrant being included within the offering.
An over-allotment option has also been granted, enabling the company to raise up to an additional 15%. The financing is currently slated to close by February 15.
Proceeds from the capital raise are earmarked for sales and marketing, general and working capital purposes, as well as strategic acquisitions.
Nanalysis Scientific last traded at $1.25 on the TSX Venture.
Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.